Home
>
National Drug Code (NDC)
>
Aldara
Aldara - 99207-260-12 - (imiquimod)
Drug Information of Aldara
| Product NDC: | 99207-260 |
| Proprietary Name: | Aldara |
| Non Proprietary Name: | imiquimod |
| Active Ingredient(s): | 50 mg/g & nbsp; imiquimod |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Aldara
| Product NDC: | 99207-260 |
| Labeler Name: | Medicis Pharmaceutical Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020723 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20111128 |
Package Information of Aldara
| Package NDC: | 99207-260-12 |
| Package Description: | 12 PACKET in 1 CARTON (99207-260-12) > .25 g in 1 PACKET |
NDC Information of Aldara
| NDC Code | 99207-260-12 |
| Proprietary Name | Aldara |
| Package Description | 12 PACKET in 1 CARTON (99207-260-12) > .25 g in 1 PACKET |
| Product NDC | 99207-260 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | imiquimod |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20111128 |
| Marketing Category Name | NDA |
| Labeler Name | Medicis Pharmaceutical Corp |
| Substance Name | IMIQUIMOD |
| Strength Number | 50 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] |
